Learn Whether BPC-157 is Right for You at Dr
Heart, kidney, and other health effects Heart health: Semaglutide (Ozempic) lowers the risk of major cardiovascular events in adults with type 2 diabetes and known cardiovascular disease
In the Triumph-4 Phase III trial involving adults with obesity and knee osteoarthritis, participants receiving the highest dose of retatrutide lost an average of 28.7% of their body weight over 68 weeks, roughly 71.2 pounds, and experienced a 75.8% decrease in pain scores associated with osteoarthritis-related knee pain
Third-party literature - not product claims Two distinct peptides in this set: CJC-1295 (No DAC), also called Modified GRF(1-29), and Ipamorelin (NNC 26-0161)
Retatrutide lowers blood sugar in non-diabetics by 0.5-1% on average through GLP-1 and GIP effects, but monitor levels to prevent hypoglycemia